← Evidence map

ReviewClinical pharmacology and therapeutics2025

IQ Survey Results on Current Industry Practices-Part 1: Immunogenicity Risk Assessment.

Christine Grimaldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39876095